🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
The TRANQUILITY Trial: Multi-Center Randomized, Double-Masked, Parallel Des...
Status
Completed
Location
University Clinical Health
Start Date
2020-11-21
Trial ID
NCT04674358
Treatments Being Tested
This study will examine the efficacy and safety of tivanisiran sodium eye d...
Status
Completed
Location
Sylentis Investigative Site
Start Date
2021-05-25
Trial ID
NCT04819269
Treatments Being Tested
The purpose of this study is to determine if Moxidex otic solution is safe ...
Status
Terminated
Location
Contact Alcon Call Center for Trial Locations
Start Date
2010-02
Trial ID
NCT01071902
Treatments Being Tested
Phase 3 study to evaluate the extended safety of RVL-1201 compared to place...
Status
Completed
Location
Barnet, Dulany Perkins
Start Date
2018-06-20
Trial ID
NCT03536949
Treatments Being Tested
The purpose of this study is to determine the safety of Nevanac 0.1% compar...
Status
Completed
Location
Contact Alcon for Trial Locations
Start Date
2006-02
Trial ID
NCT00332774
A Phase 2, randomized, double-blind, dose rising study to determine the saf...
Status
Completed
Location
Moore Clinical Research
Start Date
2017-05-18
Trial ID
NCT03083470
Treatments Being Tested